The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Plasminogen activator inhibitor 1—insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence
Open accessAbstract
Cellular senescence is widely believed to play a key role in tumor suppression, but the molecular pathways that regulate senescence are only incompletely understood. By using a secretome proteomics approach, we identified insulin-like growth factor binding protein 3 (IGFBP3) as a secreted mediator of breast cancer senescence upon chemotherapeutic drug treatment. The senescence-inducing activity of IGFBP3 is inhibited by tissue-type plasminogen activator-mediated proteolysis, which is counteracted by plasminogen activator inhibitor 1 (PAI-1), another secreted mediator of senescence. We demonstrate that IGFBP3 is a critical downstream target of PAI-1-induced senescence. These results suggest a role for an extracellular cascade of secreted proteins in the regulation of cellular senescence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other related factors, such as IGFBP3, have been implicated as SASP components that may play a role in the propagation of senescence signals to neighboring cells (42).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [42]
In the citing paper
“For example, PAI-1, a SASP factor produced by many cell types, can stabilize IGFBP3 by inhibition of tissue plasminogen activator, which normally cleaves it.”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [42]
In the citing paper
“The ability of IGFBP3 to induce senescence is regulated by tissue-type plasminogen activator inhibitor-1 (PAI-1) system (Elzi et al., 2012).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Elzi et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Keller, A., Nesvizhskii, A., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,970
A statistical model for identifying proteins by tandem mass spectrometry.
Nesvizhskii, A., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,902
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., & Aebersold, R. (1999) · Nature Biotechnology · doi:10.1038/13690 · Cited by 4,683
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence-messaging secretome: SMS-ing cellular stress
Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R. L., Velasco-Miguel, S., Takenaka, I. M., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Kortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637 · cited 3×
“Ectopic expression of PAI-1 was sufficient to induce senescence in human and mouse fibroblasts (22).”
BackgroundInfluential(2003) · PubMed · Cited by 608
Hallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
Li, X., Zhang, H., Ranish, J. A., & Aebersold, R. H. (2003) · Analytical Chemistry · doi:10.1021/ac034633i · Cited by 342
Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Jogie‐Brahim, S., Feldman, D., & Oh, Y. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0028 · Cited by 326
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 2×
“Further, recent studies have begun to uncover profound alterations in protein secretion from senescent cells, which is collectively called the senescence-associated secretory phenotype (SASP) (4, 5) or senescence-messaging secretome (SMS) (6).”
BackgroundQuantitative proteome analysis using isotope-coded affinity tags and mass spectrometry
Shiio, Y., & Aebersold, R. H. (2006) · Nature Protocols · doi:10.1038/nprot.2006.22 · Cited by 207
Self-citationMurano, S., Thweatt, R., Shmookler Reis, R. J., Jones, R. A., Moerman, E. J., & Goldstein, S. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.3905 · Cited by 199
Samson, A. L., & Medcalf, R. L. (2006) · Neuron · doi:10.1016/j.neuron.2006.04.013 · Cited by 196
Quantitative proteomic analysis of Myc oncoprotein function
Shiio, Y., Donohoe, S., Yi, E. C., Goodlett, D. R., Aebersold, R. H., & Eisenman, R. N. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf525 · Cited by 183
Self-citationPerspectives in mammalian IGFBP-3 biology: local vs. systemic action
Yamada, P. M., & Lee, K. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00598.2008 · Cited by 174
Mari, D., Coppola, R., & Provenzano, R. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.06.014 · Cited by 147
Kunz, C., Pebler, S., Otte, J., & von der Ahe, D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3710 · Cited by 145
Goldstein, S., Moerman, E. J., Jones, R. A., & Baxter, R. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9680 · Cited by 104
Kim, K. S., Kim, M., Seu, Y. B., Chung, H. Y., Kim, J. H., & Kim, J. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00315.x · Cited by 91
Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression
Sieuwerts, A. M., Vries, J. B.-D., Bosma, P. T., Swiggers, S. J. J., Klijn, J. G. M., Foekens, J. A., & Martens, J. W. M. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613457 · Cited by 79
Quantitative Proteomic Analysis of Myc-induced Apoptosis
Shiio, Y., Suh, K. S., Lee, H., Yuspa, S. H., Eisenman, R. N., & Aebersold, R. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509349200 · Cited by 70
Self-citationMu, X., & Higgins, P. J. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650324 · Cited by 58
A chemotherapy-associated senescence bystander effect in breast cancer cells
Di, X., Bright, A. T., Bellott, R., Gaskins, E., Robert, J., Holt, S., Gewirtz, D. A., & Elmore, L. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.5861 · Cited by 57
Grimberg, A., Coleman, C. M., Burns, T. F., Himelstein, B. P., Koch, C. J., Cohen, P., & El‐Deiry, W. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1213 · Cited by 55
Bang, P., & Fielder, P. J. (1997) · Endocrinology · doi:10.1210/endo.138.9.5371 · Cited by 41
Parra, M., Jardı́, M., Koziczak, M., Nagamine, Y., & Muñoz‐Cánoves, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103735200 · Cited by 31
Lai, Y., Qiao, M., Song, M., Weintraub, S. T., & Shiio, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016975 · Cited by 23
Self-citation
Cited by
Sorted by citations
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
How the ageing microenvironment influences tumour progression
Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849
IGF binding proteins in cancer: mechanistic and clinical insights
Baxter, R. C. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3720 · Cited by 525
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Palmer, A. K., Tchkonia, T., LeBrasseur, N. K., Chini, E. N., Xu, M., & Kirkland, J. L. (2015) · Diabetes · doi:10.2337/db14-1820 · Cited by 423
Metadata
- Authors
- Elzi, D. J., Lai, Y., Song, M., Hakala, K., Weintraub, S. T., & Shiio, Y.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-07-09
- Volume
- 109
- Issue
- 30
- Pages
- 12052-12057
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3409757
- OpenAlex
- W2074103997
- Cited by
- 154
- References
- 34
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 17 · 2023: 11 · 2022: 11 · 2021: 11 · 2020: 11 · 2019: 11 · 2018: 10 · 2017: 13 · 2016: 15 · 2015: 13 · 2014: 8 · 2013: 5
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA054174)
- University of Texas Health Science Center at San Antonio
- National Institute on Aging (R21AG029587, AG029587)
- National Cancer Institute (CA-054174, P30CA054174, R01CA125020, CA125020, CA137568, R21CA137568)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- cellular senescence, insulin-like growth factor binding protein-3, plasminogen activator inhibitor-1, tissue plasminogen activator, breast cancer, chemotherapy-induced senescence, secretome, tumor suppression, proteolysis
- MeSH terms
- Analysis of Variance, beta-Galactosidase, Culture Media, Doxorubicin, Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Neoplasms, Tissue Plasminogen Activator, Stress, Physiological, Tumor Cells, Cultured, Immunoblotting, Cellular Senescence, Plasminogen Activator Inhibitor 1, DNA Primers, Insulin-Like Growth Factor Binding Protein 3, Reverse Transcriptase Polymerase Chain Reaction, RNA, Small Interfering, Proteomics, Cell Line, Tumor, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
